Fears for global health R&D after US budget battle
Friday, April 4, 2014
Future research and development targeting diseases such as HIV,tuberculosis and malaria may be at risk because of across-the-board federal cuts implemented last year by the United States, the largest funder of global health R&D, warns a report.
The United States has helped fund the development of 53 per cent of the 45 vaccines, drugs, diagnostics and devices that were brought to the global health market between 2000 and 2010, according to a report delivered to Congress last week (27 March) by the Global Health Technologies Coalition.
In addition, US support is aiding the development of 200 of the 365 global health products moving through the R&D pipeline, according to the coalition of not-for-profit organisations.